ASSESSMENT OF ADHERENCE WITH MEDICATIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
- 1 December 2001
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (12) , 1174-1176
- https://doi.org/10.1097/00006454-200112000-00017
Abstract
The purpose of this study was to determine the reliability of screening for medication adherence in HIV-infected children. The results suggest that caregivers who are unable to describe the medication regimen or who are nonadherent with appointments are unlikely to adhere to the medication regimen. Adherence with at least 90% of medication doses was associated with a virologic response.Keywords
This publication has 17 references indexed in Scilit:
- Adherence to medication regimens among children with human immunodeficiency virus infectionThe Pediatric Infectious Disease Journal, 2000
- Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377AIDS Research and Human Retroviruses, 2000
- Reduction in Mortality With Availability of Antiretroviral Therapy for Children With Perinatal HIV-1 InfectionJAMA, 2000
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Telephoning the patient’s pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptionsThe Journal of Pediatrics, 2000
- Sociodemographic and psychological variables influencing adherence to antiretroviral therapyAIDS, 1999
- Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1The Pediatric Infectious Disease Journal, 1999
- Adherence to Antiretroviral and Pneumocystis Prophylaxis in HIV DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Potential factors affecting adherence with HIV therapyAIDS, 1997
- In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and FrequenciesThe Journal of Infectious Diseases, 1996